Items where Subject is "P > Pharmaceutical industry"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Creators | Item Type
Jump to: B | G | M | S
Number of items at this level: 6.

B

Bertini, M and Tavassoli, N T (2015) Case study: Can one business unit have 2 revenue models? Harvard Business Review, 93 (3). pp. 121-123. ISSN 0017-8012

G

Gallien, J, Rashkova, I, Atun, R and Yadav, P (2016) National drug stockout risks and the global fund disbursement process for procurement. Production and Operations Management, 26 (6). pp. 997-1014. ISSN 1059-1478 OPEN ACCESS

M

Morgan, S G, Cunningham, C and Law, M R (2012) Drug development: innovation or imitation deficit? British Medical Journal, 345 (e5880). ISSN 0959-8138

Morgan, S and Cunningham, C (2008) The effect of evidence-based drug coverage policies on pharmaceutical R&D: a case study from British Columbia. Healthcare Policy, 3 (3). e128-e153.

Morgan, S, Grootendorst, P, Lexchin, J and Cunningham, C (2011) The cost of drug development: a systematic review. Health Policy, 100 (1). pp. 4-17. ISSN 0168-8510

S

Sivanathan, N and Hakkar, K (2017) The unintended consequences of argument dilution in direct-to-consumer drug advertisments. Nature Human Behaviour, 1 (11). pp. 797-802. ISSN 2397-3374 OPEN ACCESS

This list was generated on Sun Oct 21 01:02:15 2018 BST.